EKSO Ekso Bionics Holdings Inc
- Stocks
- Healthcare
- NASDAQ: EKSO
Price (delayed)
$3.63
Market cap
$9.48M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$6.64
Enterprise value
$9.63M
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications. Founded in 2005, Ekso
Highlights
EKSO's EPS is up by 44% year-on-year and by 10% since the previous quarter
The debt is down by 19% YoY and by 4% QoQ
The net income has grown by 11% YoY but it has contracted by 2.7% from the previous quarter
The gross profit has declined by 20% year-on-year and by 19% since the previous quarter
Ekso Bionics Holdings's revenue has decreased by 19% YoY and by 16% from the previous quarter
Key stats
What are the main financial stats of EKSO
Market
Valuations
Earnings
Shares outstanding
2.61M
Market cap
$9.48M
Enterprise value
$9.63M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.64
Price to sales (P/S)
0.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.66
Revenue
$14.65M
Gross profit
$7.55M
Operating income
-$12.28M
Net income
-$11.09M
EBIT
-$10.81M
EBITDA
-$9.25M
Free cash flow
-$9.2M
Per share
Balance sheet
Liquidity
EPS
-$6.64
EPS diluted
-$6.64
Free cash flow per share
-$4.22
Book value per share
$5.65
Revenue per share
$6.72
TBVPS
$8.49
Total assets
$23.17M
Total liabilities
$12.24M
Debt
$5.39M
Equity
$10.93M
Working capital
$9.26M
Debt to equity
0.49
Current ratio
2.38
Quick ratio
1.46
Net debt/EBITDA
-0.02
Margins
Efficiency
Dividend
EBITDA margin
-63.1%
Gross margin
51.5%
Net margin
-75.7%
Operating margin
-83.8%
Return on assets
-41.7%
Return on equity
-86.6%
Return on invested capital
-83.5%
Return on capital employed
-65.7%
Return on sales
-73.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EKSO stock price
How has the Ekso Bionics Holdings stock price performed over time
Intraday
10.33%
1 week
-17.5%
1 month
10.33%
1 year
-77.17%
YTD
-60.33%
QTD
10.33%
Financial performance
How have Ekso Bionics Holdings's revenue and profit performed over time
Revenue
$14.65M
Gross profit
$7.55M
Operating income
-$12.28M
Net income
-$11.09M
Gross margin
51.5%
Net margin
-75.7%
EKSO's operating margin is down by 38% QoQ and by 27% YoY
The net margin is down by 23% QoQ and by 11% YoY
The gross profit has declined by 20% year-on-year and by 19% since the previous quarter
Ekso Bionics Holdings's revenue has decreased by 19% YoY and by 16% from the previous quarter
Price vs fundamentals
How does EKSO's price correlate with its fundamentals
Growth
What is Ekso Bionics Holdings's growth rate over time
Valuation
What is Ekso Bionics Holdings stock price valuation
P/E
N/A
P/B
0.64
P/S
0.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.66
EKSO's EPS is up by 44% year-on-year and by 10% since the previous quarter
EKSO's P/B is 66% below its 5-year quarterly average of 1.9 and 36% below its last 4 quarters average of 1.0
Ekso Bionics Holdings's equity has decreased by 14% QoQ and by 9% YoY
The stock's price to sales (P/S) is 78% less than its 5-year quarterly average of 2.5 and 33% less than its last 4 quarters average of 0.8
Ekso Bionics Holdings's revenue has decreased by 19% YoY and by 16% from the previous quarter
Efficiency
How efficient is Ekso Bionics Holdings business performance
EKSO's return on sales is down by 23% since the previous quarter and by 10% year-on-year
The ROIC has contracted by 9% from the previous quarter
The ROA has contracted by 6% from the previous quarter but it has grown by 2.6% YoY
The ROE has grown by 6% YoY but it has contracted by 5% from the previous quarter
Dividends
What is EKSO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EKSO.
Financial health
How did Ekso Bionics Holdings financials performed over time
Ekso Bionics Holdings's total assets is 89% more than its total liabilities
EKSO's total liabilities is down by 18% YoY and by 16% QoQ
Ekso Bionics Holdings's total assets has decreased by 15% from the previous quarter and by 14% YoY
The debt is 51% lower than the equity
The debt is down by 19% YoY and by 4% QoQ
Ekso Bionics Holdings's equity has decreased by 14% QoQ and by 9% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.